Relative presence during brain death evaluation: a systematic review
In brief
Family presence during brain death testing improves understanding without clear evidence of added distress
Across nine studies, relatives who witnessed brain death evaluation consistently better understood that death had occurred; the only randomized trial found no increase in psychological distress. Evidence on organ donation consent was inconclusive, and the research base is small and concentrated in a few countries, so larger studies are needed to guide how hospitals offer supported family presence.
- Journal
- Journal of critical care (Q1)
- Published
- 20 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Fabio Del Duca, Michele Treglia, Maria Grazia Bocci, Paola Frati, Luca Casertano, Aniello Maiese
- PMID
- 43063663
- DOI
- 10.1016/j.jcrc.2026.155823
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (top studies of the week, 22 November 2026): Systematic review informs family presence during brain-death evaluation
Abstract
Bereavement following brain death declaration can be profoundly traumatic for relatives, and the outcomes associated with their presence during brain death evaluation warrant careful evaluation. Brain death can be declared while cardiopulmonary function is still mechanically maintained, a dissociation that can be difficult for families to reconcile with what they are told. This review aimed to assess whether relative presence during brain death evaluation affects family comprehension, psychological and grief-related outcomes, and organ donation consent. We conducted a systematic search across PubMed, ScienceDirect, Scopus, and Google Scholar. Nine studies met the inclusion criteria, comprising one randomized controlled trial, one prospective multicenter trial, one retrospective cohort study, two survey studies, three qualitative studies, and one case series. Across studies, family presence was consistently associated with better comprehension that death had occurred. The only randomized trial found no increase in psychological distress, measured with the Impact of Event Scale and General Health Questionnaire-12, among family members who were present compared with those who were absent. Most data on how often presence is offered predate current international guidance, and evidence on whether presence affects organ donation consent was inconclusive. The evidence base is small, methodologically heterogeneous, and concentrated in a few countries, resting on a single randomized trial. Where offered, family presence is consistently facilitated through a structured, staff-supported model rather than unstructured bedside access. Since 2014, only 22 patients' families have been studied at the bedside, although international guidance now encourages their presence. Larger, prospectively registered, multicenter trials reporting outcomes from relatives are needed to test these recommendations.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.